News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Seattle-based biotech startup Sana raises $821 million
“I think the most important thing in building a company and the thing that we want inside Sana is finding a mission that will change
Genmab, Seattle Genetics eye FDA filing for new cancer med after latest data drop
Seattle Genetics and Genmab, a Danish biotechnology company, announced a 24% response rate for their joint cervical cancer medication tisotumab vedotin, paving the way for
Sana Biotechnology has big plans after securing $700M initial financing
Sana Biotechnology, a Seattle-based company developing cell and gene therapies, announced it has raised more than $700 million to aid in the discovery and development
This ventilator company vaulted into middle market after $400M government contract
Bothell, Washington’s Ventec Life Systems partnered with General Motors to rapidly scale their ventilator manufacturing capabilities during the onset of COVID-19. They are on track
AbbVie spends $60M, with $80.5M in biobucks, for Alpine Immune’s lupus asset
Seattle-based Alpine Immune Sciences announced a $60M licensing agreement with AbbVie Inc. for its ALPN-101 midstage lupus and autoimmune asset. Under the pact, AbbVie grabs
BARDA and Immunexpress Inc. expand partnership to evaluate a sepsis host-based laboratory diagnostic to triage COVID-19 patients
Biomedical Advanced Research and Development Authority (BARDA) announced a collaboration with Seattle’s Immunexpress Inc. to determine the risk of sepsis in hospitalized COVID-19 patients. READ
Adaptive Biotechnologies and Microsoft team up to track coronavirus-fighting cells
Adaptive Biotechnologies and Microsoft announced a new project to address COVID-19, called ImmuneCODE. The project tracks how the immune system fights COVID-19 and aims to
Seattle biotech firm scores $85 million for work on Alzheimer’s drug, despite hurdles of coronavirus pandemic
Athira Pharma, a Seattle-based biotechnology company, secured $85 million in a Series B round. The additional financing will support Athira Pharma’s Phase 2/3 Alzheimer’s clinical
‘Start innovating like crazy’: Fast-moving genomics startup turns to R&D to navigate the pandemic
Phase Genomics, a Seattle-based life science company, that maps and analyzes genomes, is focusing its attention inward and renewing its R&D efforts during the pandemic.
Seattle Children’s Hospital and Prevencio: The Hunt to Understand COVID-19’s Connection to Kawasaki Disease
Seattle Children’s Hospital is working with blood-testing startup Prevencio to develop a blood test to detect certain proteins and blood components leading to a firm
Seattle researchers building ‘biobank’ of patients’ blood to unlock the mysteries of the new coronavirus
The Institute for Systems Biology (ISB) and Swedish Health are building a “biobank” to study COVID-19’s impact on the human body. According to Dr. Jim
Nautilus emerges with $76M to become the ‘Illumina of proteomics’
Seattle headquartered, Nautilus Biotechnology announced a $76 million series B round to fund its work analyzing and quantifying the human proteome. Nautilus Biotechnology is looking